Trial intelligence / Profile preview

Effect of vitamin D substitution on insulin resistance, metabolic control and lymphocyte function in patients with type 2 diabetes mellitus

2006-006180-23Phase 3Terminated

Sponsor
Goethe University Frankfurt
Start
Apr 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Vigantol Oil (cholecalciferol) with Placebo Oil (2 arms). Primary endpoint: Insulin resistance change (primary). Started Apr 2007; status: terminated.

02

Drugs

vitamin d
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2006-006180-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006180-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call